Literature DB >> 17145224

Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction.

Adriana Lopes Latado1, Luiz Carlos Santana Passos, Eduardo S Darzé, Antônio Alberto Lopes.   

Abstract

Patients with symptomatic heart failure (HF) frequently have preserved left ventricular (LV) ejection fractions (LVEFs). Although anemia is a common finding in this patient population, its prognostic role has not been well studied. This study's aim was to assess if the LVEF interferes in the association between anemia and in-hospital mortality in patients with severe HF. Consecutive patients admitted to an intensive care unit with decompensated chronic HF were prospectively enrolled. The diagnosis of HF was based on clinical criteria. Patients with LVEFs > or =45% (on echocardiography) were diagnosed as having preserved LVEFs. Multivariate analysis was performed to test the independent association between anemia and in-hospital mortality and to evaluate an interaction between anemia and systolic function. In all, 303 patients were recruited (mean age 69 +/- 13 years; 45.5% women). Preserved LVEFs were present in 34% of the population. The prevalence of anemia in this group was 58%, compared with 43% in the group with systolic dysfunction (p = 0.01). Dilated left ventricles, left bundle branch blocks, and valvular dysfunction were significantly more frequent in patients with systolic heart failure. In-hospital mortality was similar in the groups with preserved LVEFs and systolic dysfunction (p = 0.71). On multivariate analysis, anemia was independently associated with in-hospital mortality (odds ratio 2.7, 95% confidence interval 1.43 to 5.04, p = 0.002). There was no interaction between anemia and systolic function (p = 0.08 for interaction). In conclusion, anemia was an independent predictor of in-hospital mortality in symptomatic patients with severe HF, regardless of whether the patients had preserved or impaired LV systolic function.

Entities:  

Mesh:

Year:  2006        PMID: 17145224     DOI: 10.1016/j.amjcard.2006.07.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  The prognostic value of anemia in patients with diastolic heart failure.

Authors:  Faramarz Tehrani; Anita Phan; Ryan Morrissey; Christopher Chien; Asim Rafique; Ernst R Schwarz
Journal:  Tex Heart Inst J       Date:  2009

2.  Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function.

Authors:  Luigi Tarantini; Fabrizio Oliva; Silvia Cantoni; Giovanni Cioffi; Virginia Agnoletto; Gianfranco Alunni; Francesca De Cian; Andrea Di Lenarda; Donata Lucci; Giovanni Pulignano; Laura Scelsi; Aldo Pietro Maggioni; Luigi Tavazzi
Journal:  Intern Emerg Med       Date:  2011-05-05       Impact factor: 3.397

3.  Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.

Authors:  Mathew S Maurer; Sergio Teruya; Bibhas Chakraborty; Stephen Helmke; Donna Mancini
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

Review 4.  Anemia and the potential role of erythropoiesis-stimulating agents in heart failure.

Authors:  Haroon A Faraz; Syed F Zafar; Jalal K Ghali
Journal:  Curr Heart Fail Rep       Date:  2008-06

Review 5.  Anemia and blood transfusion: prognostic implications in patients undergoing contemporary percutaneous coronary intervention.

Authors:  Mauro Moscucci
Journal:  Curr Cardiol Rep       Date:  2009-09       Impact factor: 2.931

6.  Baseline characteristics of patients with heart failure and preserved ejection fraction at admission with acute heart failure in Saudi Arabia.

Authors:  Samah Abohammar; Mona Adel ElSaidy; Diaa Fathalla; Mubarak Aldosarri
Journal:  Egypt Heart J       Date:  2016-09-03

7.  Left ventricular outflow tract velocity time integral in hospitalized heart failure with preserved ejection fraction.

Authors:  Kazunori Omote; Toshiyuki Nagai; Hiroyuki Iwano; Shingo Tsujinaga; Kiwamu Kamiya; Tadao Aikawa; Takao Konishi; Takuma Sato; Yoshiya Kato; Hirokazu Komoriyama; Yuta Kobayashi; Kazuhiro Yamamoto; Tsutomu Yoshikawa; Yoshihiko Saito; Toshihisa Anzai
Journal:  ESC Heart Fail       Date:  2019-12-18

8.  Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease.

Authors:  Keisuke Okuno; Yoshiro Naito; Masanori Asakura; Masataka Sugahara; Tetsuo Horimatsu; Seiki Yasumura; Saki Tahara; Toshiyuki Nagai; Yoshihiko Saito; Tsutomu Yoshikawa; Tohru Masuyama; Masaharu Ishihara; Toshihisa Anzai
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.